In the United States, oral ivermectin is a prescription drug. As of 28 September 2026, FDA's Orange Book lists 17 human ivermectin product rows across 15 applications, and every oral tablet row is prescription or discontinued — the only human ivermectin carrying over-the-counter marketing status is the 0.5% topical lotion for head lice (FDA Orange Book data files, products.txt, September 2026 edition). So the practical question behind most ivermectin prescriptions is not whether one is needed, but what a prescriber has to do before writing it and what a pharmacist has to satisfy themselves of before filling it.

This page walks through that chain: what makes a prescription legally valid, why off-label prescribing is lawful without changing anything on the label, what the prescriber writes, and what a pharmacist independently checks. If you are weighing buying online through a licensed route, the same rules apply — FDA's consumer page says that if a health care provider writes an ivermectin prescription, you should fill it through a legitimate source such as a pharmacy (page content current as of 5 April 2024).

Key takeaways

  • Federal law, 21 U.S.C. 353(b)(1), sets which human drugs may be dispensed only on a practitioner's prescription, and 353(b)(4)(A) requires the label of such a drug to bear at minimum the symbol "Rx only".
  • FDA's own consumer page states that, with few exceptions, health care professionals may choose to prescribe an approved human drug for an unapproved use when they judge it medically appropriate for an individual patient. That does not add an indication to the label.
  • The approved indications on the STROMECTOL label (revision 09/2024) are intestinal strongyloidiasis and onchocerciasis, and no FDA-approved US human ivermectin product carries an approved scabies indication.
  • As of 28 September 2026, our verified state dataset records seven states with an ivermectin access law in force; five of the seven route the decision through a pharmacist or a pharmacy rather than a prescriber, and two (Arkansas and Idaho) name no gatekeeper at all. North Dakota's statute is a prescriber shield, not an access law, and is not counted among the seven.
  • Ivermectin products such as the 1.87% equine paste are labeled for animal use only and are not approved for people; FDA's 2020 stakeholder letter states that people should never take animal drugs.

What makes a prescription legally valid in the US

A folded paper prescribing-information leaflet and plain tablet carton on a kitchen table, illustrating what the ivermectin label does and does not say.

Federal law defines the category, not the paperwork. Under 21 U.S.C. 353(b)(1) (US Code, 2024 edition), a human drug is prescription-only if, because of its toxicity or other potentiality for harmful effect, the method of its use, or the collateral measures necessary to its use, it is not safe except under the supervision of a licensed practitioner — or if its approved application limits it to such supervision. Section 353(b)(4)(A) then makes a prescription drug misbranded if its label fails to bear at a minimum the symbol "Rx only", and 353(b)(4)(B) mirrors that: putting "Rx only" on a non-prescription drug misbrands it too.

The STROMECTOL carton bears "Rx only" (DailyMed SPL, updated 20 September 2024). Animal drugs run on a separate track: 21 U.S.C. 353(f)(4) requires a veterinary prescription drug's label to bear "Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian." — and makes it misbranding to put that sentence on a non-prescription animal drug.

What federal law does not supply is the list of elements a written prescription must contain, the identity check, or the refill rules. Those come from state pharmacy practice acts and boards of pharmacy, and they differ from state to state. This article does not attempt a state-by-state list of those elements.

Off-label prescribing: why it is lawful, and what it does not change about the label

A pharmacist checking a prescription record on screen at the back bench of an independent pharmacy.

FDA states the position directly on its own consumer page: "From the FDA's perspective, with few exceptions, health care professionals may choose to prescribe or use an approved human drug for an unapproved use when they judge that the unapproved use is medically appropriate for an individual patient" (FDA, "Ivermectin and COVID-19", content current as of 5 April 2024).

One common misreading is worth heading off. The FD&C Act's "Practice of medicine" section, 21 U.S.C. 396, protects a practitioner's authority to prescribe or administer a legally marketed device. By its terms it does not cover drugs. Off-label drug prescribing rests on medical practice regulation by the states and on FDA's stated enforcement posture, not on that section.

The label stays where it is

Whatever the prescriber's reasoning, the approved labeling does not move. STROMECTOL is indicated for the treatment of strongyloidiasis of the intestinal tract and onchocerciasis; the label notes that the drug has no activity against adult Onchocerca volvulus parasites. The recommended dose is a single oral dose of approximately 200 mcg/kg for strongyloidiasis and approximately 150 mcg/kg for onchocerciasis, taken on an empty stomach with water. Generic ivermectin tablets carry the same two indications in substantively the same wording. FDA also states it has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals.

Animal formulations are a separate system

Animal ivermectin products — for example the 1.87% equine paste approved under ANADA 200-390, labeled "For Oral Use in Horses Only" — are labeled for animal use only and are not approved for use in people. FDA's stakeholder letter of 10 April 2020 recommends that people should never take animal drugs, because FDA has evaluated their safety and effectiveness only in the species for which they are labeled. The federal extralabel framework at 21 CFR 530.1 applies to extralabel use in an animal by or on the lawful order of a licensed veterinarian; it confers nothing on a physician treating a person. For the legitimate human supply chain, see all the legitimate sources.

The examination requirement, in person and by telehealth

A customer waiting at a pharmacy consultation window in a state with an ivermectin access law.

There is no single federal rule setting what examination must precede a human prescription. That requirement is written by state medical, nursing and osteopathic boards, and by state telehealth statutes; it varies by state and by profession, and we do not list those requirements here because they could not be verified state by state from primary sources for this article.

Two things are worth knowing anyway. First, the prescriber generally must be licensed in the state where the patient is located at the time of the encounter, which is why a telehealth prescription can be refused at a pharmacy counter in a different state — see prescriptions across state lines. Second, the veterinary side shows what an explicit federal examination standard looks like, for contrast: 21 CFR 530.3(i) requires, for a valid veterinarian-client-patient relationship, that the veterinarian has assumed responsibility for medical judgments with the client's agreement, has sufficient knowledge of the animal to make at least a preliminary diagnosis, and is readily available for follow-up. Human medicine has no federal counterpart to that paragraph.

What the prescriber actually writes, and why the indication may not appear on it

A woman at her kitchen table on the phone about a rejected pharmacy claim for an off-label prescription.

A prescription for oral ivermectin names the drug and strength, the quantity, the directions, refills (if any), the patient, and the prescriber with their identifiers. The strength options are narrow: the only ivermectin oral tablet strengths listed in the Orange Book are 3 mg and 6 mg. STROMECTOL 3 mg is approved under NDA 050742 with an Orange Book approval date of 8 October 1998 and remains actively marketed; the 6 mg STROMECTOL is discontinued, with a Federal Register determination that it was not discontinued or withdrawn for safety or effectiveness reasons. A 6 mg generic exists and is prescription-only, under ANDA 215922 (Rubicon Research), approved 22 January 2025.

Because the label's dosing is weight-based, the quantity often reveals the arithmetic rather than the diagnosis. STROMECTOL's strongyloidiasis table runs from 1 tablet at 15–24 kg to 5 tablets at 66–79 kg, with patients 80 kg and over dosed at 200 mcg/kg; the onchocerciasis table runs from 1 tablet at 15–25 kg to 4 tablets at 65–84 kg, with patients 85 kg and over dosed at 150 mcg/kg. Two indications, two different tables.

The diagnosis itself frequently does not appear. Whether a human prescription must state an indication is a matter of state law and plan rules, not a federal labeling requirement. Again the veterinary contrast is instructive: 21 CFR 530.12 requires a drug dispensed for extralabel use in an animal to bear labeling that includes the prescribing veterinarian's name and address, the established name of the drug, directions for use, cautionary statements, and the veterinarian's specified withdrawal time — five named elements, set out in the regulation.

Corresponding responsibility: what a pharmacist must independently check

"Corresponding responsibility" is borrowed from federal controlled-substance dispensing rules. Ivermectin is not a controlled substance, so a pharmacist's duty to verify a non-controlled prescription comes from state pharmacy practice acts and professional standards rather than from a single federal provision. In practice the pharmacist confirms the prescriber's authority and the patient's identity, then runs the clinical screen the label supports.

What the pharmacist screens What the STROMECTOL label (revision 09/2024) supplies
Contraindications One: hypersensitivity to any component of the product.
Drug interactions One entry: post-marketing reports of increased INR, rarely reported, when ivermectin was co-administered with warfarin.
Metabolism In vitro studies show ivermectin is primarily metabolized by CYP3A4.
Pediatric limits Safety and effectiveness in pediatric patients weighing less than 15 kg have not been established — a weight limit, not an age limit.
Pregnancy The label states ivermectin should not be used during pregnancy since safety in pregnancy has not been established.
Counseling Tablets should be taken on an empty stomach with water; a 30 mg dose after a high-fat meal produced an approximate 2.5-fold increase in bioavailability relative to the fasted state.
Safety warnings Neurotoxicity including altered consciousness, confusion, disorientation and death has been reported, including in patients without onchocerciasis.

Note what the label does not do: it does not list interactions with CYP3A4 inhibitors, so a pharmacist raising one is applying pharmacology, not label text. A fuller walk-through of that screen sits in the interaction check a pharmacist runs.

Why a pharmacist may decline, and what your options are then

A pharmacist may decline to fill for ordinary professional reasons — a dose outside the label's weight bands, an unresolved interaction, a pregnancy flag, an inability to verify the prescriber, or a judgment that they cannot establish that the prescription serves a legitimate medical purpose. State law governs whether and how a refusal must be handled, including transfer of the prescription; those rules vary.

We were unable to verify, from any primary source, the published dispensing policy of any national pharmacy chain for oral ivermectin. Reports of chain-level policies circulate widely; we are not restating them as fact here. If you are turned down, the workable options are to ask the pharmacist what specifically blocked the fill, to have the prescriber call the pharmacy directly, to ask for the prescription to be transferred to another pharmacy, or — in the handful of states described below — to ask whether a pharmacist-led route applies.

What gets recorded, and who can see it

A filled prescription generates a pharmacy dispensing record, an entry in the prescriber's chart, and, if it is billed, a claim record held by the insurer or pharmacy benefit manager. Retention periods for pharmacy records are set by state boards of pharmacy and differ; we do not state a single national figure. Prescription drug monitoring programs are built around controlled substances, which ivermectin is not.

The veterinary system again gives a concrete federal number for comparison: under 21 CFR 530.5(b), a veterinarian must keep extralabel use records for 2 years or as otherwise required by Federal or State law, whichever is greater — a floor, not a ceiling.

Insurance and off-label indications: why claims are often rejected

Plans adjudicate by indication and by formulary rules. A claim for oral ivermectin written for one of the two labeled indications behaves like any other generic claim; a claim tied to an unapproved use is where prior authorization, step therapy or an outright rejection usually appears. A rejection is a coverage decision, not a statement that the prescription is invalid.

Public acquisition-cost data gives some sense of scale, though it is not a retail price. CMS's national average drug acquisition cost, effective 23 September 2026, was $1.99423 per 3 mg ivermectin tablet, $9.80491 per 6 mg tablet, $2.74609 per gram for generic 1% cream, and $1.23937 per gram for the 0.5% lotion, which CMS flags as OTC (CMS NADAC 2026 dataset). NADAC measures what pharmacies pay, not what you are charged. We could not verify any US consumer retail or cash price from a primary source; our page on what you will pay explains that limitation rather than quoting a number we cannot stand behind.

What happens at the counter in a state with an access law

As of 28 September 2026, our verified state-law dataset — built from each state's own legislative record — records seven states with an ivermectin access law in force — states where a pharmacy can supply human ivermectin without a patient-specific prescription. The mechanisms are not interchangeable.

State Law Mechanism Who decides at the counter In force
Arkansas SB 189, Act 396; Ark. Code Ann. § 20-7-147 OTC by statute No gatekeeper named Date not recorded in our tracker
Idaho S 1211 (2025); Idaho Code § 37-135 OTC by statute No gatekeeper named 14 April 2025
Iowa HF 2676; Iowa Code § 126.24 OTC by statute The pharmacy 1 July 2026
Louisiana SB 19 (2025 RS), Act 464; La. R.S. 37:1218.3 Standing order The pharmacist 20 June 2025
Missouri SB 878 (2026), merged with HB 2372; Mo. Rev. Stat. § 338.208 Pharmacist protocol The pharmacist 28 August 2026
Tennessee SB 2188 / HB 2746, Public Chapter 908 (2022); Tenn. Code Ann. § 63-10-224 Pharmacist collaborative practice agreement The pharmacist 22 April 2022
Texas HB 25 (89th Legislature, 2nd Called Session); Tex. Health & Safety Code ch. 446, § 446.001 Pharmacist protocol The pharmacist 4 December 2025

Two cautions. A state access law changes who may authorize the dispensing inside that state; it does not change the federal label, does not add an approved indication, and does not make the product something other than an FDA-approved human drug. North Dakota is the state most often miscounted in press round-ups, and it is not one of the seven. Its statute — HB 1514 (2021 Special Session), N.D.C.C. § 43-15-42.4, in force 15 November 2021 — protects a prescriber or pharmacist from discipline or liability for prescribing or dispensing ivermectin. It creates no new route for a patient: a prescription is still required, which is why it does not appear in the table above. Our page on states where a pharmacist can dispense directly goes through each mechanism. We claim no access law for any state not listed above.

Questions worth asking your prescriber and your pharmacist

For the prescriber

  • Is this prescription for one of the two labeled indications, or off-label? If off-label, what is the evidence you are relying on, and how strong is it?
  • What dose did you calculate, and from what body weight?
  • Am I in a group the label flags — under 15 kg, pregnant, or taking warfarin?
  • Are you licensed in the state I am physically in during this visit?
  • Will you write the indication on the prescription or the chart note, in case my plan asks?

For the pharmacist

  • Do you stock the strength written, and if not, can you order it or transfer the prescription?
  • Does anything on my medication list interact, beyond what the label lists?
  • Should I take this on an empty stomach, and what should I avoid around the dose?
  • If the claim rejects, what is the rejection code, and is a prior authorization possible?
  • If I am in one of the seven states above, does your pharmacy operate under that law, and what does it require of me?

Frequently asked questions

Do you need a prescription for ivermectin?

For oral ivermectin tablets, yes. Across the Orange Book's ivermectin tablet rows as of the 11 September 2026 data file, none carries over-the-counter marketing status. The one human ivermectin product with OTC status is the 0.5% topical lotion for head lice. A small number of states have enacted their own access laws, listed above.

How do you get an ivermectin prescription?

Through a licensed prescriber who evaluates you — in person or by telehealth where your state permits it — and judges the drug appropriate. FDA's consumer page says that if a provider writes the prescription, it should be filled through a legitimate source such as a pharmacy.

Is off-label prescribing of ivermectin legal?

FDA's stated position is that, with few exceptions, health care professionals may prescribe an approved human drug for an unapproved use when they judge it medically appropriate for an individual patient. Medical practice is regulated by the states, and a prescriber remains answerable to their state board. Lawful is not the same as supported by evidence, and the label remains limited to intestinal strongyloidiasis and onchocerciasis.

Can I use the horse paste instead?

Equine ivermectin paste is labeled for oral use in horses only and is not approved for use in people. FDA's 10 April 2020 stakeholder letter recommends that people should never take animal drugs, because FDA has evaluated their safety and effectiveness only in the labeled species. Concentration, excipients and measurement in these products are designed for animal body weights.

What about ordering from a website that does not ask for a prescription?

FDA has issued warning letters treating such sales as the introduction of misbranded and unapproved new drugs into interstate commerce — for example its 16 March 2023 warning letter to an ivermectin website. We do not name or link such sellers.

Can a compounding pharmacy supply ivermectin without a prescription?

No. Compounding under 21 U.S.C. 353a(a) applies to a product compounded for an identified individual patient based on receipt of a valid prescription order, so compounding is not an over-the-counter route.

Is the pharmacist allowed to overrule my doctor?

A pharmacist does not overrule a diagnosis, but they do exercise an independent professional judgment about dispensing, under their state practice act. If they decline, ask what specifically blocked the fill; many refusals turn on a resolvable detail such as a missing weight, an unverified prescriber, or an interaction that needs a phone call.

Sources